FERYXA prép inj perf 100 mg/2ml 5 flac 2 ml
7680694120012
CH-69412
B03AC
06.07.1.
1 / 3
google
Details
- Product number
- 6941201
- CPT
- -
- Packaging group
- 5 x 2 ml
- Unit
- Ampulle(n)
- Composition
- ferrum 100 mg ut ferricum carboxymaltosum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium max. 11 mg.
Articles (1)
Feryxa 100 mg / 2 ml, Dispersion zur Injektion/Infusion
Ampullen
5 x 2 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 54.45
Specialties list
Yes
Generic
No
SL addition date:
01/01/2024
Authorization holder
Vifor (International) Inc.
9014 St. Gallen
Authorization information
- Swissmedic authorization number
- 69412
- Drug name
- Feryxa, Dispersion zur Injektion/Infusion
- Galenic form
- DISII
- ATC Code
- B03AC
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 21/07/2023
- Authorization expiration date
- 31/12/9999
- IT number
- 06.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FERYXA prép inj perf 100 mg/2ml 5 flac 2 ml
- Description (DE)
- FERYXA Inj Inf Präp 100 mg/2ml 5 Durchstf 2 ml
- Market launch
- 21/07/2023
- Narcotic (BTM)
- No